Background: Preparations from roots of Salvia miltiorrhiza, a herb widely used in traditional Chinese medicine, have been reported to induce a series of central effects, including sedation. In the wake of this ethnopharmacological information, the present study was designed to assess the anxiolytic potential of an extract of S. miltiorrhiza roots. Methods: To this end, rats were acutely treated with S. miltiorrhiza extract (0, 50, and 100 mg/kg; i.g.) and exposed to the Elevated Plus Maze (EPM) test. The effect of treatment with S. miltiorrhiza extract on Stress-Induced Hyperthermia (SIH; a physiological response to stressful events) was also evaluated. Results: Treatment with 100 mg/kg S. miltiorrhiza extract produced robust anxiolytic effects at the EPM test; specifically, it increased (a) percent of entries into open arms, (b) percent of time spent in open arms, (c) total number of head dips, (d) number of unprotected head dips, and (e) number of end-arm explorations in open arms, without any alteration in spontaneous locomotor activity. Treatment with 100 mg/kg S. miltiorrhiza extract also suppressed SIH response. The anxiolytic effects produced by 100 mg/kg S. miltiorrhiza extract were comparable to those exerted by acute treatment with 1.5 mg/kg (i.p.) of the reference compound, diazepam.
Introduction
Salvia miltiorrhiza Bunge (Labiatae) is a native plant of China; it also grows in Japan, Korea, and Mongolia. Its dried roots, often referred to as Danshen, are listed in the Chinese Pharmacopoeia and constitute one of the most commonly used herbal remedies in Chinese folk medicine. 1 Preparations containing S. miltiorrhiza roots are used to treat a range of pathologies, including coronary heart disease, angina pectoris, cerebrovascular diseases, ischemic stroke, hepatitis, hyperlipidemia, diabetes, Alzheimer's disease, Parkinson's disease, and insomnia. 2e4 The use of herbal preparations containing S. miltiorrhiza roots has recently been expanding also in several Western Countries. 2e4 The major, biologically-active chemical constituents of S. miltiorrhiza roots are diterpene pigments e of orange-red color and with a phenanthrenequinone structure e such as tanshinone I, tanshinone IIA, tanshinone IIB, cryptotanshinone, and miltirone. 2, 3 The traditional use of S. miltiorrhiza roots as a "calming" or sedative remedy 3 suggests that they may exert anxiolytic effects. With the intent of contributing towards clarifying Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
whether S. miltiorrhiza roots produce anxiolysis, the present study evaluated the effect of an extract of S. miltiorrhiza roots in two validated rodent models of anxiety: the Elevated Plus Maze (EPM) test and the Stress-Induced Hyperthermia (SIH) test. To our knowledge, no study has experimentally evaluated the anxiolytic potential of extracts of S. miltiorrhiza roots. Therefore, the present study was designed with the intent of (a) proving experimentally several reports from traditional medicines on the "calming", or anxiolytic, properties of herbal preparations containing S. miltiorrhiza roots and (b) providing experimental bases for subsequent investigations aimed at identifying the underlying neural substrates and the active ingredients involved.
EPM is one of the most widely used procedures to assess anxiety-related behaviors in rodents. It is based on the innate unconditioned fear of rodents for open, heightened, and unprotected environments (resulting in avoidance) and their preference for sheltered, enclosed, and dark spaces (resulting in approach). 5e7 Specifically, the EPM test measures the conflict of rats and mice between the instinct to explore the open, unprotected arms of the maze and the proclivity to explore its closed, safe arms. Administration of anxiolytic compounds (e.g., benzodiazepines) markedly increased the proportion of time spent in and number of entries into the open arms of the maze; conversely, administration of anxiogenic compounds (e.g., pentylenetetrazole, yohimbine, and caffeine) suppressed the proportion of explorations in the open arms in favor of those in the closed arms. 5 Validity and reliability of the EPM procedure have further been improved by recording of several behavioral, anxiety-related measures (e.g., exploration and activity in the distal portion of the open arm; head dips below the level of the open arm) and measures of risk-assessment responses [e.g., stretch-attend postures (SAPs)]. 6, 7 These additional measures, along with the initial spatiotemporal measures, provide a comprehensive and ethologically-based evaluation of the rat behavior and, in pharmacological tests, of the effect of the tested drug. 6, 8 SIH test measures the innate increase in mammal body temperature, mediated by the autonomic nervous system, in response to exposure to situations perceived as threatening or distressing. 9 Experimentally, individual body temperature of rats and mice is measured twice, before (T1) and after (T2) exposure to a given stressor: the difference in body temperature (DT ¼ T2 À T1) is defined as SIH response. SIH response is pharmacologically manipulable (at least in terms of its reduction), as several anxiolytic compounds (e.g., benzodiazepines) have been reported to produce its suppression. 10 In the present study, the SIH test was associated to the EPM test: the anxiogenic and stress-induced stimuli producing SIH comprised indeed all those interventions required to perform the EPM test [i.e.: rat move from the homecage to the waiting cage (together with temporary isolation); rat move from the housing room to the waiting room; rat move from the waiting room to the testing room; rat exposure to the EPM].
The anxiolytic effect of the S. miltiorrhiza extract was compared to that of the benzodiazepine, diazepam, that was included in the experimental design as standard anxiolytic compound.
Methods
The experimental procedures employed in the present study were (a) in accordance with European Directive no. 2010/63/ EU and subsequent Italian Legislative Decree no. 26, March 4, 2014, on the "Protection of animals used for scientific purposes".
Animals
Male Wistar rats (n ¼ 53) (Envigo, San Pietro al Natisone, Italy), of 6e7 weeks of age and weighing approximately 250 g, were used. Rats were housed 3/cage in standard plastic cages with wood chip bedding. The animal facility was under a reversed 12:12 h lightedark cycle (lights on at 9:00 p.m.), at a constant temperature of 22 ± 2 C and relative humidity of approximately 60%. Behavioral tests were conducted during the first 4 h of the dark phase of the light/dark cycle. Food pellets (standard rodent chow; Envigo, San Pietro al Natisone, Italy) and tap water were always available (24 h/day), with the sole exception of the 2 h before administration of S. miltiorrhiza extract, when food pellets were removed so that rats had empty stomachs at the time of extract infusion. Over the two weeks preceding the start of each experiment, rats underwent daily 10-min sessions during which they were extensively habituated to handling and intragastric infusion (experiment testing S. miltiorrhiza extract), or intraperitoneal injection (experiment testing diazepam).
Apparatus
The EPM apparatus (Med Associates, St. Albans, VT, USA) was made of black plexiglas and consisted of 4 arms [12(w) Â 60(l) cm] positioned to form a plus sign. Two opposite facing arms had 50(h)-cm walls and open roof (closed arms), whereas the other two opposite facing arms had no walls (open arms), but only a 0.5(h)-cm border. The arms were connected by a 12 Â 12-cm central square. The entire maze was elevated 50 cm above the floor. A custom-made, computer-controlled, video-tracking system was used to record rat behavior. The EPM apparatus was located in a soundproof room adjacent to both waiting and testing rooms.
Body temperature was monitored by means of a rectal thermometer for rodents (Keithley Instruments, Cleveland, OH, USA) with 0.1 C accuracy.
Experimental procedure
Two independent experiments were conducted, one testing S. miltiorrhiza extract and one testing diazepam. On the test day of each experiment, rats were divided into three (experiment testing S. miltiorrhiza extract) or two (experiment testing diazepam) groups, carefully matched for body weight.
Baseline (T1) body temperature was taken immediately before pharmacological treatment. At T1, two consecutive recordings (30 s apart) were performed in each rat; the value assigned to each rat was given by the average of these two recordings.
Immediately after T1 recording of body temperature, rats were treated with 0 (n ¼ 11), 50 (n ¼ 11), and 100 (n ¼ 11) mg/kg S. miltiorrhiza extract or 0 (n ¼ 10) and 1.5 (n ¼ 10) mg/kg diazepam. S. miltiorrhiza extract (Danshen Extract Powder, Xi'an Honson Biotechnology Co. Ltd., Xi'an, China) (i) was prepared from dried roots of S. miltiorrhiza, extracted with ethanol, and (ii) contained 10.1% tanshinone IIA. S. miltiorrhiza extract was dissolved in a 1:1 mixture of Tween 80 and PEG 600. The solution was kept under continuous agitation, at room temperature and in a dark container, for at least 12 consecutive hours before administration. S. miltiorrhiza extract was administered acutely and intragastrically (by means of a metal gavage) at the infusion volume of 2 ml/kg.
Diazepam (injectable Valium
® , Roche, Monza, Italy) was dissolved in a 1:1 mixture of saline and PEG 600. Diazepam was administered acutely and intraperitoneally at the injection volume of 2 ml/kg.
Immediately after pharmacological treatment, rats were singly housed in waiting cages and moved from the housing room to the waiting room. Sixty minutes after administration of S. miltiorrhiza extract and 30 min after administration of diazepam, rats were moved from the waiting room to the testing room (where the EPM was located) and exposed to the EPM.
Each Entry into a given arm was scored once the rat had all 4 paws in that arm. 7 Head dips were scored anytime the rat had moved the head below the level of the maze floor. 7 End-arm explorations in open arms were defined as the rat reaching, with all 4 paws, the last 10-cm portion of an open arm. 11 SAPs were defined as the rat being motionless but stretching to its full length with the forepaws toward a stimulus (i.e., an open arm), keeping the hindpaws in the same place, and then resuming the initial position. 7 Number of entries into closed arms was recorded as measure of spontaneous locomotor activity. 7, 12, 13 Percent of entries into open arms, percent of time spent in open arms, total number of head dips, number of unprotected head dips, and number of end-arm explorations in open arms were recorded as measures of anxiety-related behaviors. 7, 12, 13 Number of protected head dips was recorded as measure of decisionmaking and assessment of height and openness from the central square. 13 Number of SAPs was recorded as measure of risk assessment. 6, 14 At the end of each single test, the maze was cleaned thoroughly before exposure of the following rat.
Immediately after termination of the EPM test (i.e., 65 min after infusion of S. miltiorrhiza extract or 35 min after injection of diazepam), body temperature was re-recorded (T2); T2 recording of body temperature was performed in the same way as T1 recording.
Statistical analysis
Data from the EPM test were initially tested for normality using the D'Agostino and Pearson test. In the experiment testing S. miltiorrhiza extract, when normally distributed, data were analyzed by 1-way ANOVA, followed by the NewmaneKeuls test for post hoc analysis; when not normally distributed, data were analyzed by the KruskaleWallis test, followed by the Dunn's test for post hoc analysis. In the experiment testing diazepam, when normally distributed, data were analyzed by the 2-tailed Student t test; when not normally distributed, data were analyzed by the 2-tailed ManneWhitney test.
In both "S. miltiorrhiza extract" and "diazepam" experiments, data on SIH response were analyzed by 2-way (treatment; time) ANOVA for repeated measures on the factor "time", followed by the NewmaneKeuls test for post hoc comparisons.
Results

Elevated plus maze
Locomotor activity
Treatment with S. miltiorrhiza extract did not alter basal locomotor activity, as indicated by the lack of any difference in number of entries into closed arms between vehicle-treated rat group and the two S. miltiorrhiza extract-treated rat groups [F(2,30) ¼ 0.92, p > 0.05] (Fig. 1A) .
Similarly, no difference in number of entries into closed arms was observed between vehicle-and diazepam-treated rat groups ( p > 0.05, Student t test) ( (Fig. 1D) . Treatment with 100 mg/kg S. miltiorrhiza extract produced an approximately 2.5-fold increase, in comparison to vehicle treatment, in total number of head dips ( p < 0.005, NewmaneKeuls test); conversely, treatment with 50 mg/kg S. miltiorrhiza extract was ineffective.
ANOVA indicated that treatment with S. miltiorrhiza extract significantly altered the number of unprotected head dips [F(2,30) ¼ 8.33, p < 0.005] (Fig. 1E) . Treatment with 100 mg/kg S. miltiorrhiza extract produced an approximately 3.5-fold increase, in comparison to vehicle treatment, in number of unprotected head dips ( p < 0.005, NewmaneKeuls test); conversely, treatment with 50 mg/kg S. miltiorrhiza extract was ineffective. in Wistar rats exposed to the Elevated Plus Maze (EPM) test. Salvia miltiorrhiza extract was administered intragastrically 60 min before the EPM test. The EPM test lasted 5 min. Each bar is the mean ± SEM of n ¼ 11 rats. *: p < 0.05, **: p < 0.005, and ***: p < 0.0005 in comparison to the rat group treated with 0 mg/kg Salvia miltiorrhiza extract (NewmaneKeuls or Dunn's test).
Decision-making
ANOVA indicated that treatment with S. miltiorrhiza extract failed to alter the number of protected head dips [F(2,30) ¼ 1.07, p > 0.05] (Fig. 1G) . Data suggest the presence of a tendency toward an increase in the number of protected head dips in the rat group treated with 100 mg/kg S. miltiorrhiza extract, in comparison to vehicle-treated rat group.
Treatment with diazepam exerted no more than a tendency toward an increase in the number of protected head dips ( p > 0.05, Student t test) ( Table 1) .
Risk assessment
ANOVA indicated that treatment with S. miltiorrhiza extract significantly altered the number of SAPs [F(2,30) ¼ 8.86, p < 0.001] (Fig. 1H) (Fig. 2) .
ANOVA indicated a highly significant effect of treatment with diazepam [F(1,18) 
Discussion
Data from both tests (EPM and SIH) consistently indicate that acute treatment with an extract of S. miltiorrhiza roots exerted robust anxiolytic effects in rats. The results of the Diazepam was administered intraperitoneally 30 min before the EPM test. The EPM test lasted 5 min. Each figure is the mean ± SEM of n ¼ 10 rats. *: p < 0.05, **: p < 0.005, and ***: p < 0.0005 in comparison to the rat group treated with 0 mg/kg diazepam (2-tailed Student t test or 2-tailed ManneWhitney test). Fig. 2 . Effect of the acute administration of two different doses of an extract of Salvia miltiorrhiza roots on stress-induced hyperthermia (measure of "anxiety") in Wistar rats exposed to a sequence of stressful events, comprising all those interventions required to perform the Elevated Plus Maze (EPM) test. Salvia miltiorrhiza extract was administered intragastrically 60 min before the EPM test. Rat body temperature was recorded twice: at T1 (baseline; immediately before treatment with Salvia miltiorrhiza extract) and T2 (immediately after termination of the EPM test, i.e. 65 min after treatment with Salvia miltiorrhiza extract). At both T1 and T2, two consecutive recordings (30 s apart) were performed in each rat; the value assigned to each rat was given by the average of these two recordings. Each bar is the mean ± SEM of n ¼ 11 rats. $ : p < 0.001 in comparison to the same rat group at T1 (NewmaneKeuls test); # : p < 0.005 in comparison to the rat group treated with 0 mg/kg Salvia miltiorrhiza extract at T2 (NewmaneKeuls test).
EPM experiment indicate anti-anxiety behaviors in both primary, spatiotemporal measures, as treatment with S. miltiorrhiza extract increased (a) percent of entries into open arms and (b) percent of time spent in open arms. At the dose of 100 mg/kg S. miltiorrhiza extract this increase was remarkably large, with both variables averaging 40e45%. These figures suggest that treatment with 100 mg/kg S. miltiorrhiza extract rendered the two opposite environments of the EPM (open and closed arms) almost equivalent in terms of the rats' emotional response; in other words, treatment with 100 mg/kg S. miltiorrhiza extract produced anxiolytic effects strong enough to induce the rats to approach and explore the heightened and unprotected open arms (otherwise mostly avoided) in a manner highly comparable to that by which they approached and explored the dark and sheltered closed arms. Importantly, the above differences do not seem to be the mere consequence of non-specific alterations in the rats' general motor activity or state of well-being, as none of the two doses of S. miltiorrhiza extract altered the number of entries into the closed arms, a validated and reliable measure of spontaneous locomotor activity in rats and mice exposed to the EPM. 7, 12, 13 To summarize, treatment with S. miltiorrhiza extract altered the quality, rather than the quantity, of exploratory behavior of the rats exposed to the EPM.
Additional elements in favor of the anxiolytic effect of S. miltiorrhiza extract are provided by the analysis of several ethological measures of anxiety. These measures include (a) total number of head dips, (b) number of unprotected head dips, and (c) number of end-arm explorations in open arms; these measures complement with the two above spatiotemporal measures, providing a more complete profiling of the rat behavior at the EPM test. Treatment with 100 mg/kg S. miltiorrhiza extract markedly increased the frequency of all three different behaviors, confirming that this dose of S. miltiorrhiza extract was capable of producing robust anxiolysis at the EPM test.
Analysis of data on risk assessment provides additional, interesting details on the pharmacological profile of the tested S. miltiorrhiza extract. Risk assessment stands for a repertoire of behaviors that animals execute to gather information when facing a potentially dangerous situation, such as a novel and aversive environment. In the EPM test, risk assessment mainly consists in SAPs, i.e. the forward elongations of head and shoulders from the central square or a closed arm and toward an open arm, followed by retraction to the original, "safe" position; SAPs are made with the intent of assessing the precariousness of the opposing environment. Besides being representation of a decision-making process, SAPs incorporate elements of "anxiety", as suggested by the numerous pharmacological data reporting their suppression after treatment with well-established anxiolytic agents. 12, 15, 16 In the present study, treatment with both doses of S. miltiorrhiza extract reduced, in a dose-related fashion, the number of SAPs; these data can be interpreted proposing that, due to the anxiolytic effect of S. miltiorrhiza extract, body elongations from the closed arms toward the open arms, with rapid returns to the original positions, were replaced e in large part e by full entries into and explorations of the open arms.
SIH test produced consistent results: treatment with 100 mg/kg S. miltiorrhiza extract completely abolished the increase in rat body temperature secondary to the stressful events associated to rat exposure to the EPM test. These data confirm, and extend to a physiological response to stressful and anxiogenic events, that the S. miltiorrhiza extract tested in the present study possesses anti-stress and anxiolytic properties in rats.
Notably, the anxiolytic effect of S. miltiorrhiza extract resulted to be highly comparable, at both EPM and SIH tests, to that exerted by diazepam, a reference anxiolytic compound in preclinical behavioral pharmacology. In the present study, diazepam was tested at a dose (1.5 mg/kg, i.p.) in the range of those well-known to effectively suppress several anxietyrelated behaviors in rats without altering basal motor activity and coordination. 5,17e20 The similarity in magnitude of the anxiolytic effect of S. miltiorrhiza extract and diazepam confers further relevance to the behavioral pharmacological profile of S. miltiorrhiza extract.
In close agreement with the results of the present study, a recent study found that non-sedative doses of an essential oil obtained from the aerial parts of S. miltiorrhiza exerted robust anxiolytic effects in rats exposed to EPM and Social Interaction tests. 21 These data, together with those of the present study, suggest that all parts of S. miltiorrhiza e both aerial parts 21 and roots e are sources of agents with anxiolytic action in rats. Notably, none of the diterpenes proposed as active ingredients of preparations from S. miltiorrhiza roots was contained in that specific essential oil of the aerial parts. 21 This suggests that S. miltiorrhiza contains a large variety of active compounds with anxiolytic potential.
Additional, indirect support to the anxiolytic profile of preparations from S. miltiorrhiza roots may come from the results of a previous study demonstrating that acute administration of miltirone, one of the main active ingredients of S. miltiorrhiza roots, produced anxiolytic effects in mice exposed to a punishment-induced conflict test. 22 Miltirone has been reported to behave as partial agonist at the benzodiazepine ) were performed in each rat; the value assigned to each rat was given by the average of these two recordings. Each figure is the mean ± SEM of n ¼ 10 rats. *: p < 0.0005 in comparison to the same rat group at T1 (NewmaneKeuls test); **: p < 0.0005 in comparison to the rat group treated with 0 mg/kg diazepam at T2 (NewmaneKeuls test).
binding site, 22e24 providing a clue on the mechanism of its anxiolytic action.
The results of the present study also provide a possible key to the interpretation of different lines of experimental evidence on the reducing effect of extracts of S. miltiorrhiza roots on multiple alcohol-related behaviors. Acute and repeated treatment with different extracts of S. miltiorrhiza roots has indeed been reported to reduce alcohol drinking (including relapse-like drinking) and operant self-administration of alcohol in rats. 25e29 These results have been collected entirely in Sardinian alcohol-preferring (sP) rats, a rat line selectively bred for high alcohol preference and consumption. 30 Besides alcohol preference, sP rats display inherent predisposition to anxiety-related behaviors, as demonstrated using several different experimental procedures, including EPM. 30 Notably, voluntarily consumed alcohol markedly reduced these anxiety-related behaviors, 31, 32 suggesting that anxiolysis is likely one of the alcohol effects that drive sP rats to seek and consume large amounts of alcohol. Accordingly, it is conceivable that the anxiolytic effects of extracts of S. miltiorrhiza roots substituted for those of alcohol, making alcohol seeking and drinking less urgent and resulting in the observed reductions in alcohol drinking and selfadministration. If theoretically transposed to humans, these data suggest that S. miltiorrhiza extracts would represent a potentially effective, therapeutic option for those alcoholic patients with comorbid anxiety and alcohol use disorder.
In conclusion, the results of the present study indicate that acute treatment with an extract of S. miltiorrhiza roots exerted robust anxiolytic effects in two experimental procedures validated to detect anxiety-related behaviors in rats.
